跳至主要内容
临床试验/DRKS00010495
DRKS00010495
招募中
不适用

Atrial mechanics as predictors of atrial fibrillation’s recurrence after pulmonary vein isolation - EchoAM-AF

niveristy Hospital Centre Sisters of Charity0 个研究点目标入组 150 人2016年5月10日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
I48.0
发起方
niveristy Hospital Centre Sisters of Charity
入组人数
150
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2016年5月10日
结束日期
待定
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
niveristy Hospital Centre Sisters of Charity

入排标准

入选标准

  • Men and women, 18\-85 years of age with paroxysmal and persistent atrial fibrillation who will undergo pulmonary vein isolation and who are able to understand and sign an informed consent will be included in the study. Paroxysmal atrial fibrillation is defined as atrial fibrillation with self\-terminating episodes lasting up to a maximum of 7 days, while persistent atrial fibrillation is defined as atrial fibrillation lasting more than 7 days and/or that required the use of cardioversion (either with antiarrhytmic drugs or electrocardioversion)in ending the episode. Both definitions are taken from the international guidelines of the European Society for Arrhythmias (EHRA) which is part of the European Society of Cardiology (ESC).

排除标准

  • 1\. Patients on whom the pulmonary vein isolation was already done (re\-do PVIs)
  • 2\. Patients with \< 40% left ventricular ejection fraction
  • 3\. Patients with persistent atrial fibrillation lasting longer \> 12 months (long lasting atrial fibrillation) or permanent atrial fibrillation
  • 4\. Patients with contraindication for using anticoagulant therapy
  • 5\. Patients with intracavitary clot which is contraindication for pulmonary vein isolation
  • 6\. Patients on whom cavotricuspid isthmus ablation was done
  • 7\. Patients on whom echocardiography was not done or it was of low quality
  • 8\. Patients who are not in sinus rhythm at the time of performing echocardiography
  • 9\. Patients with implanted permanent pacemaker or cardioverter\-defibrilator or CRT
  • 10\. Patients who underwent cardiothoracic surgery (myocardial revascularisation and/or valvular reparation or replacement)

结局指标

主要结局

未指定

相似试验